quality of care

News

12/16/2020

Journal of Clinical Pathways

Business Briefs

Exploring New Opportunities for Physicians to Expand Their Reach

08/02/2019

Information regarding coding, coverage, and payment is provided as a service to our readers. Every effort has been made to ensure accuracy. However, HMP and the author do not represent, guarantee, or warranty that coding, coverage, and...

Information regarding coding,...

08/02/2019

Today's Wound Clinic

Interview

Prostate Cancer Treatment Varies Between General Population, Diagnosed Men

01/11/2019

JCP Editors

Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...

...

01/11/2019

Journal of Clinical Pathways

News

High Risk of Preventable and Mitigable Adverse Events in Cancer Care

08/22/2017

JCP Editors

Researchers have identified a significant burden of adverse events across the cancer care continuum, including preventable or mitigable events, according to a study published in Cancer (online August 17, 2017;...

...

08/22/2017

Journal of Clinical Pathways

News

Breast Cancer Survival Outcomes After Mastectomy Versus Breast-Conserving Surgery

08/22/2017

JCP Editors

A recent comparative effectiveness study examined long-term survival outcomes for patients with multiple stages of breast cancer after undergoing either mastectomy or breast-conserving surgery, published in the...

A...

08/22/2017

Journal of Clinical Pathways

Research in Review

Patients With MCL and a Specific Mutation in Need of Alternative Frontline Therapies

08/21/2017

JCP Editors

Patients with mantle cell lymphoma (MCL) should be stratified based on the status of a specific mutation and considered for alternative first-line therapy, according to a new study published in Blood (online August...

...

08/21/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Study Examines Treatment Options for DLBCL

08/18/2017

JCP Editors

A recent study compared the treatment effects and adverse events of first-line chemotherapy regimens in patients with treatment-naïve diffuse large B-cell lymphoma (DLBCL). Rituximab plus cyclophosphamide,...

A...

08/18/2017

Journal of Clinical Pathways

Research in Review

Patient Values, Concerns Influence Breast Cancer Treatment Decisions

08/17/2017

JCP Editors

Researchers examined the decision-making processes of patients with breast cancer to understand why a procedure that does not improve survival is increasingly being considered. ----- Related Content Contralateral...

...

08/17/2017

Journal of Clinical Pathways

Research in Review

Resistance Mutations Predict Metastatic Patterns in NSCLC

08/17/2017

JCP Editors

Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research...

...

08/17/2017

Journal of Clinical Pathways

Perspectives

Pharmaceutical Manufacturer Responses to Health Care Professional and Clinical Pathway Developer Requests for Medical Information

08/16/2017

JR Meloro , BA;

AnnaMaria D'Ascoli , BS, PharmD, MBA;

Teresa McShane , PhD, DVM;

Abstract: Oncology is one of the most complex and rapidly changing fields in medicine. Both practicing health care professionals (HCPs) and developers of clinical pathways require information about the latest...

...

08/16/2017

Journal of Clinical Pathways